SAN DIEGO, CA--(Marketwire - June 07, 2010) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Jefferies 2010 Global Life Sciences Conference on June 9, 2010.
The Jefferies conference is being held at the Grand Hyatt Hotel in New York, NY. Ms. Johnson is scheduled to present on Wednesday, June 9th at 10:30 am Eastern Time. The audio broadcast of this presentation can be accessed at http://www.wsw.com/webcast/jeff46/cypb/.
A replay of the presentation will be available at the same web address as well as on Cypress’ website, http://www.cypressbio.com/events.php.
About Cypress Bioscience
Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella® (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.
For more information about Cypress, please visit the Company’s website at www.cypressbio.com.
For additional information please contact
Mary Gieson
Investor Relations Manager
(858) 452-2323
Email Contact
